Literature DB >> 12894006

Hospital volume, length of stay, and readmission rates in high-risk surgery.

Philip P Goodney1, Therese A Stukel, F Lee Lucas, Emily V A Finlayson, John D Birkmeyer.   

Abstract

OBJECTIVE: Aimed at reducing surgical deaths, several recent initiatives have attempted to establish volume-based referral strategies in high-risk surgery. Although payers are leading the most visible of these efforts, it is unknown whether volume standards will also reduce resource use.
METHODS: We studied postoperative length of stay and 30-day readmission rate after 14 cardiovascular and cancer procedures using the 1994-1999 national Medicare database (total n = 2.5 million). We used regression techniques to examine the relationship between length of stay, 30-day readmission, and hospital volume, adjusting for age, gender, race, comorbidity score, admission acuity, and mean social security income.
RESULTS: Mean postoperative length of stay ranged from 3.4 days (carotid endarterectomy) to 19.6 days (esophagectomy). There was no consistent relationship between volume and mean length of stay; it significantly increased across volume strata for 7 of the 14 procedures and significantly decreased across volume strata for the other 7. Mean length of stay at very-low-volume and very-high-volume hospitals differed by more than 1 day for 6 procedures. Of these, the mean length of stay was shorter in high-volume hospitals for 3 procedures (pancreatic resection, esophagectomy, cystectomy), but longer for other procedures (aortic and mitral valve replacement, gastrectomy). The 30-day readmission rate also varied widely by procedure, ranging from 9.9% (nephrectomy) to 22.2% (mitral valve replacement). However, volume was not related to 30-day readmission rate with any procedure.
CONCLUSION: Although hospital volume may be an important predictor of operative mortality, it is not associated with resource use as reflected by length of stay or readmission rates.

Entities:  

Mesh:

Year:  2003        PMID: 12894006      PMCID: PMC1422689          DOI: 10.1097/01.SLA.0000081094.66659.c3

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  51 in total

1.  Medicare home health agency utilization, 1984-1994.

Authors:  G Picone; R M Wilson
Journal:  Inquiry       Date:  1999       Impact factor: 1.730

2.  The hospital volume-outcome relationship in general thoracic surgery. Is the surgeon the critical determinant?

Authors:  J D Urschel; D M Urschel
Journal:  J Cardiovasc Surg (Torino)       Date:  2000-02       Impact factor: 1.888

3.  Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer.

Authors:  S G Swisher; L Deford; K W Merriman; G L Walsh; R Smythe; A Vaporicyan; J A Ajani; T Brown; R Komaki; J A Roth; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2000-06       Impact factor: 5.209

4.  Potential benefits of regionalizing major surgery in Medicare patients.

Authors:  J D Birkmeyer; F L Lucas; D E Wennberg
Journal:  Eff Clin Pract       Date:  1999 Nov-Dec

5.  Cut inpatient utilization in half with proper use of home health services.

Authors: 
Journal:  Public Sect Contract Rep       Date:  1999-06

6.  Selective referral to high-volume hospitals: estimating potentially avoidable deaths.

Authors:  R A Dudley; K L Johansen; R Brand; D J Rennie; A Milstein
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

7.  Relationship of hospital size, case volume, and cost for coronary artery bypass surgery: analysis of 12,774 patients operated on in Massachusetts during fiscal years 1995 and 1996.

Authors:  D M Shahian; G J Heatley; G A Westcott
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

8.  The effect of hospital volume on mortality and resource use after radical prostatectomy.

Authors:  L M Ellison; J A Heaney; J D Birkmeyer
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

9.  Illness severity and costs of admissions at teaching and nonteaching hospitals.

Authors:  L I Iezzoni; M Shwartz; M A Moskowitz; A S Ash; E Sawitz; S Burnside
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

10.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04
View more
  78 in total

1.  Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision.

Authors:  Kah Hoong Chang; Myles J Smith; Oliver J McAnena; Arifin S Aprjanto; Joe F Dowdall
Journal:  Int J Colorectal Dis       Date:  2012-03-08       Impact factor: 2.571

2.  A validated, risk assessment tool for predicting readmission after open ventral hernia repair.

Authors:  P A Baltodano; Y Webb-Vargas; K C Soares; C W Hicks; C M Cooney; P Cornell; K K Burce; T M Pawlik; F E Eckhauser
Journal:  Hernia       Date:  2015-08-19       Impact factor: 4.739

3.  Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.

Authors:  Donald J Lucas; Adil Haider; Elliot Haut; Rebecca Dodson; Christopher L Wolfgang; Nita Ahuja; John Sweeney; Timothy M Pawlik
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

Review 4.  Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Intensive Care Med       Date:  2006-11-18       Impact factor: 17.440

Review 5.  Outcomes in oncologic surgery: does volume make a difference?

Authors:  David J Bentrem; Murray F Brennan
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

Review 6.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

7.  Lessons learned from 300 consecutive pancreaticoduodenectomies over a 25-year experience: the "safety net" improves the outcomes beyond surgeon skills.

Authors:  Roberto Santoro; Roberto Luca Meniconi; Pasquale Lepiane; Giovanni Vennarecci; Gianluca Mascianà; Marco Colasanti; Eugenio Santoro; Giuseppe Maria Ettorre
Journal:  Updates Surg       Date:  2017-09-01

Review 8.  Influence of Hospital Volume Effects and Minimum Caseload Requirements on Quality of Care in Pancreatic Surgery in Germany.

Authors:  Christian Krautz; Axel Denz; Georg F Weber; Robert Grützmann
Journal:  Visc Med       Date:  2017-03-30

9.  Variation in surgical-readmission rates and quality of hospital care.

Authors:  Thomas C Tsai; Karen E Joynt; E John Orav; Atul A Gawande; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

10.  Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.

Authors:  Bruce G Wolff; Fabrizio Michelassi; Todd M Gerkin; Lee Techner; Kathie Gabriel; Wei Du; Bruce A Wallin
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.